314 related articles for article (PubMed ID: 25581117)
1. Women aged 75 years and older benefit from mammography.
Printz C
Cancer; 2015 Jan; 121(2):165. PubMed ID: 25581117
[No Abstract] [Full Text] [Related]
2. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years with a high or low risk of breast cancer: socioeconomic status, parity, and age at birth of first child.
Hellquist BN; Czene K; Hjälm A; Nyström L; Jonsson H
Cancer; 2015 Jan; 121(2):251-8. PubMed ID: 25242087
[TBL] [Abstract][Full Text] [Related]
3. Higher mammography screening costs without appreciable clinical benefit: the case of digital mammography.
Kerlikowske K; Hubbard R; Tosteson AN
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25031310
[No Abstract] [Full Text] [Related]
4. How best to determine the mortality benefit from screening mammography: dueling results and methodologies from Canada.
Harris RP
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274580
[No Abstract] [Full Text] [Related]
5. To screen or not to screen women in their 40s for breast cancer: is personalized risk-based screening the answer?
Mandelblatt JS; Stout N; Trentham-Dietz A
Ann Intern Med; 2011 Jul; 155(1):58-60. PubMed ID: 21727294
[No Abstract] [Full Text] [Related]
6. Evidence to Support Screening Women in Their 40s.
Ray KM; Price ER; Joe BN
Radiol Clin North Am; 2017 May; 55(3):429-439. PubMed ID: 28411671
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer Screening in Average-Risk Women.
Ann Intern Med; 2019 Apr; 170(8):. PubMed ID: 30959524
[No Abstract] [Full Text] [Related]
8. Cost-effectiveness analysis for breast cancer screening: double reading versus single + CAD reading.
Sato M; Kawai M; Nishino Y; Shibuya D; Ohuchi N; Ishibashi T
Breast Cancer; 2014 Sep; 21(5):532-41. PubMed ID: 23104393
[TBL] [Abstract][Full Text] [Related]
9. Re: Pan-Canadian study of mammography screening and mortality from breast cancer.
Narod SA; Giannakeas V; Miller AB
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25855706
[No Abstract] [Full Text] [Related]
10. Re: Performance of first mammography examination in women younger than 40 years.
Eisinger F
J Natl Cancer Inst; 2010 Nov; 102(22):1742; author reply 1742, 1742-3. PubMed ID: 20966429
[No Abstract] [Full Text] [Related]
11. Pan-Canadian study of mammography screening and mortality from breast cancer.
Coldman A; Phillips N; Wilson C; Decker K; Chiarelli AM; Brisson J; Zhang B; Payne J; Doyle G; Ahmad R
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274578
[TBL] [Abstract][Full Text] [Related]
12. Benefits and Harms of Screening Mammography by Comorbidity and Age: A Qualitative Synthesis of Observational Studies and Decision Analyses.
Braithwaite D; Walter LC; Izano M; Kerlikowske K
J Gen Intern Med; 2016 May; 31(5):561-72. PubMed ID: 26831305
[TBL] [Abstract][Full Text] [Related]
13. Sustaining mammography screening among the medically underserved: a follow-up evaluation.
Davis TC; Arnold CL; Bennett CL; Wolf MS; Liu D; Rademaker A
J Womens Health (Larchmt); 2015 Apr; 24(4):291-8. PubMed ID: 25692910
[TBL] [Abstract][Full Text] [Related]
14. Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations.
Pace LE; He Y; Keating NL
Cancer; 2013 Jul; 119(14):2518-23. PubMed ID: 23605683
[TBL] [Abstract][Full Text] [Related]
15. Screening mammography for women under 50: considerations for fully informed decision making.
Ernster VL
Womens Health; 1996; 2(4):257-60; discussion 261-6. PubMed ID: 9453858
[No Abstract] [Full Text] [Related]
16. Screening mammography in women aged 70 to 79 years.
Xu W; Vnenchak P; Smucny J
J Fam Pract; 2000 Mar; 49(3):266-7. PubMed ID: 10735487
[No Abstract] [Full Text] [Related]
17. Mammography screening: a new estimate of number needed to screen to prevent one breast cancer death.
Hendrick RE; Helvie MA
AJR Am J Roentgenol; 2012 Mar; 198(3):723-8. PubMed ID: 22358016
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of mammography screening in Hong Kong Chinese using state-transition Markov modelling.
Wong IO; Kuntz KM; Cowling BJ; Lam CL; Leung GM
Hong Kong Med J; 2010 Jun; 16 Suppl 3():38-41. PubMed ID: 20601733
[No Abstract] [Full Text] [Related]
19. Analysis of benefit:risk ratio and mortality reduction for the UK Breast Screening Programme.
Beckett JR; Kotre CJ; Michaelson JS
Br J Radiol; 2003 May; 76(905):309-20. PubMed ID: 12763946
[TBL] [Abstract][Full Text] [Related]
20. Screening mammography benefit controversies: sorting the evidence.
Feig SA
Radiol Clin North Am; 2014 May; 52(3):455-80. PubMed ID: 24792649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
